These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 11392040

  • 21. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 22. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B, Kural N, Colak O, Ak I, Akcar N.
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [Abstract] [Full Text] [Related]

  • 23. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC.
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [Abstract] [Full Text] [Related]

  • 24. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R, Hernández C, Segura RM, García-Arumí J, Sararols L, Burgos R, Cantón A, Mesa J.
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [Abstract] [Full Text] [Related]

  • 25. High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes.
    Bergen K, Brismar K, Tehrani S.
    Growth Horm IGF Res; 2016 Aug; 29():78-82. PubMed ID: 27400272
    [Abstract] [Full Text] [Related]

  • 26. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N.
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [Abstract] [Full Text] [Related]

  • 27. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease.
    Ezzat VA, Duncan ER, Wheatcroft SB, Kearney MT.
    Diabetes Obes Metab; 2008 Mar; 10(3):198-211. PubMed ID: 18269635
    [Abstract] [Full Text] [Related]

  • 28. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 29. The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.
    Krsek M, Prázný M, Marek J, Skrha J, Justová V, Lacinová Z.
    Growth Horm IGF Res; 2002 Feb; 12(1):54-9. PubMed ID: 12127302
    [Abstract] [Full Text] [Related]

  • 30. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 31. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [Abstract] [Full Text] [Related]

  • 32. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 33. The serum levels of proinsulin and their relationship with IGFBP-1 in obese children.
    Kamoda T, Saitoh H, Inudoh M, Miyazaki K, Matsui A.
    Diabetes Obes Metab; 2006 Mar; 8(2):192-6. PubMed ID: 16448523
    [Abstract] [Full Text] [Related]

  • 34. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
    Loukovaara M, Leinonen P, Teramo K, Nurminen E, Andersson S, Rutanen EM.
    Diabet Med; 2005 Apr; 22(4):434-9. PubMed ID: 15787669
    [Abstract] [Full Text] [Related]

  • 35. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [Abstract] [Full Text] [Related]

  • 36. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
    Han HJ, Kang CW, Park SH.
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
    [Abstract] [Full Text] [Related]

  • 37. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 38. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 39. Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.
    Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR.
    Diabetes Care; 2002 Oct; 25(10):1807-12. PubMed ID: 12351482
    [Abstract] [Full Text] [Related]

  • 40. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.